NeuroPace Inc. Reports 24% Revenue Surge in Q1 2025 Amidst Expanding Epilepsy Treatment MarketNeuroPace Inc. has reported a 24% increase in revenue for Q1 2025, driven by its expanding presence in the epilepsy treatment market.NeuroPace Inc Health Care Health Care Equipment & Services AI generated 2025-05-13 2 minutes to read
